Earnings Call Insights: Qiagen N.V. (NYSE:QGEN) Q4 2024 Thierry Bernard, CEO, highlighted that Qiagen surpassed its Q4 2024 ...
TOULOUSE, France & ANN ARBOR, Mich.--(BUSINESS WIRE)-- Cerenis Therapeutics, a biopharmaceutical company developing novel high-density lipoprotein (HDL) therapies to treat cardiovascular and metabolic ...
WASHINGTON, D.C. — Every day, millions of Americans make health care decisions without enough information to fully understand the trade-offs between approaches to care and make informed choices for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results